Patents by Inventor Kerri L. Kislin

Kerri L. Kislin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of identifying and treating glioblastoma
    Patent number: 9587239
    Abstract: The invention encompasses methods and kits used in the detection of invasive glioblastoma based upon the expression of NHERF-1. The methods and kits also allow prediction of disease outcome as well as therapeutic outcome.
    Type: Grant
    Filed: February 23, 2015
    Date of Patent: March 7, 2017
    Assignee: The Translational Genomics Research Institute
    Inventors: Kerri L. Kislin, Michael Edward Berens
  • METHODS OF IDENTIFYING AND TREATING GLIOBLASTOMA
    Publication number: 20150176011
    Abstract: The invention encompasses methods and kits used in the detection of invasive glioblastoma based upon the expression of NHERF-1. The methods and kits also allow prediction of disease outcome as well as therapeutic outcome.
    Type: Application
    Filed: February 23, 2015
    Publication date: June 25, 2015
    Inventors: Kerri L. Kislin, Michael Edward Berens
  • Methods and kits to identify invasive glioblastoma
    Patent number: 8962581
    Abstract: The invention encompasses methods and kits used in the detection of invasive glioblastoma based upon the expression of NHERF-1. The methods and kits also allow prediction of disease outcome as well as therapeutic outcome.
    Type: Grant
    Filed: October 29, 2009
    Date of Patent: February 24, 2015
    Assignee: The Translational Genomics Research Institute
    Inventors: Kerri L. Kislin, Michael E. Berens